SCB and CAD: Expanding the treatment indications
Anchorperson: Prof. Patrick Serruys, Ireland
Moderator: Dr. Azeem Latib, USA
Speakers: Dr. Bernardo Cortese, Dr. Antonio Colombo, Dr. Sameer Dani
Panellists: Dr. Aloke Finn, Dr. Praveen Chandra
Chatmaster: Dr. Damiano Regazzoli
Program Producer: Dr. Jean Fajadet
The ABILITY to TRANSFORM coronary artery disease treatment: innovative nano-technology based sirolimus DES and DCB platforms
Anchorperson: Alexandre Abizaid, Brazil
Moderator: Dr. Marco Valgimigli, Italy
Speakers: Dr. Fazila Malik, Dr. Luca Testa, Dr. Sandeep Basavarajaiah, Prof. Patrick Serruys, Dr. Prathap Kumar
Panellists : Prof. William Wijns
Chatmaster : Dr. Damiano Regazzoli
Program Producer: Prof. William Wijns
Whatʼs the next in DES Technology? Innovative DES platforms combining DES with DCB
Anchorperson: Prof. Roxana Mehran, USA
Moderator: Prof. Alexandre Abizaid, Brazil
Speaker: Dr. Bernhard Reimers, Dr. Iglesias Juan, Prof. Roxana Mehran, Prof. Alexandre Abizaid
Panellist: Prof. Marie-Claude Morice, Dr. Rajneesh Kapoor
Chatmaster: Dr. Antonio Mangeri
Program Producer: Dr. Christoph Naber
Details Coming Soon
Sirolimus Coated Balloon in an all-comer population
The primary endpoint of EASTBOURNE investigator-driven study presented by Dr Bernardo Cortese
EuroPCR Highlights
Need clarification?
What is MagicTouch?
MagicTouch is intended for in-stent restenosis, small vessels, bifurcation lesions and de-novo lesions.
What is Abluminus DES+?
ABLUMINUS DES+ is designed by propriety ENVISOLUTION technology in a way that addresses the unmet clinical needs especially in Diabetes Mellitus and Acute Myocardial infarction patients with Coronary Artery Disease.